Keytruda or Opdivo: Which medicine treats Lung Cancer Best?
Both of these medicines come from the same family of cancer treatment and that is immunotherapy. However, Opdivo is used with combination of other medicines and Keytruda Injection as first line for certain patients of NSCLC. Here we will know about the quality treatment of NSCLC with both of these medicines.
The primary difference in the treatment of Non-small cell lung cancer
The key point in the treatment of Keytruda Vs Opdivo for Lung Cancer falls on this primary point. PD-L1 expression that Keytruda can treat when they are at a high level. Doctor’s selection will be based on the prior treatment, cancer type, and PD-L1 expression. Thus, they will select which medicine will be good for the patient.
Qualities of Keytruda Injection
Pembrolizumab, aka Keytruda, treats more than 10 variants of cancer. It is the doctor’s most trusted medicine that has 73 to 83% treatment response and 27 to 30% complete response.
Injection keytruda has more FDA-approved indications for the treatment of lung cancer and other variants of cancer.
It treats some different types of cancer variants that opdivo is not certified to treat.
The doses of this medicine is simpler in comparison. The amount of dose and schedule to give it to kids depends on their weight. On the other hand, for adults it is the same most of the time.
Qualities of Opdivo Injection
Treats the classic variants of cancer by supporting the immune system to fight cancer. That is the similarity between these two medicines.
Can treat adults whose gastroesophageal junction cancer comes back again after chemoradiation treatment.
Reduce the possible chance of reappearance, spread, or death, but only in some patients.
Doctors mostly prescribe it in combination with Yervoy, but it is also able to treat some variants of cancer on its own.
Similarities between these Immunotherapy Medicines
Both work along with the immune system to treat cancer better.
It can treat various cancer types solely or in combination with other medicines.
FDA approves both of these medicines as the first-line treatment of cancer.
Both are useful to treat lung cancer. They almost treat this variant in a similar manner.
Almost similar side effects can develop from Keytruda and Opdivo Injections.
The prescriptions of both of these immunotherapy medicines are the same. Doctors prescribe them to take with the help of medical professional intravenously.
In Conclusion of these medicines
At the end of it, we guess one can say that Keytruda Injection is more effective in the treatment of lung cancer. Because it is eligible to treat high levels of PD-L1 expression. The side effects of it are less than Opdivo, and dosages are also simple in prescription. If one wants more details about these medicines, then they can get them from Magicine Pharma. An online pharmacy that sells all the cancer medicines at the best prices.
FAQ
Q- Which treats cancer best, Opdivo or Keytruda?
Ans- Doctors prescribe the medicines for cancer treatment under the influence of some of these facts. The stage of cancer, previous cancer treatment history, and the patient’s own health. These both treat non-small cell lung cancer in almost the same way. But keytruda can fight against the high level of PD-L1 expression.
Q- Can patients switch from Opdivo to Keytruda?
Ans- One may do the switching depending on the treatment of the type of cancer. But it will be best to discuss with the doctor before doing any drug switch.
Q- How is Keytruda better than Opdivo?
Ans– Keytruda is more efficient and works for many types of cancer variants. The dose of this medicine is more simplified with fewer side effect
